Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 October 1981:
Vol. 214. no. 4516, pp. 87 - 89
DOI: 10.1126/science.6169147
Prev | Table of Contents | Next

Articles

Science, Vol 214, Issue 4516, 87-89
Copyright © 1981 by American Association for the Advancement of Science

articles

Species restriction of a monoclonal antibody reacting with residues 130 to 137 in encephalitogenic myelin basic protein

LR Sires, S Hruby, EC Alvord Jr, I Hellstrom, KE Hellstrom, MW Kies, R Martemspm, GE Deibler, ED Beckman, and JE Casnellie

A monoclonal antibody (immunoglobulin G1) has been produced that reacts against myelin basic protein present in or extracted from the brains of many mammals-with certain important exceptions. Because of known species differences in amino acid sequences of basic protein and of certain peptide fragments, the binding site for this particular antibody appeared likely to include residues 130 to 137. Confirmation of this hypothesis was obtained by amino acid composition of the major immunoreactive peptides produced by thermolysin digestion of human basic protein and isolated by high-performance liquid chromatography.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Neurologic Symptoms Associated with Parenteral Acyclovir Treatment After Marrow Transplantation.
J. C. WADE and J. D. MEYERS (1983)
Ann Intern Med 98, 921-925
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)